Aims To determine the effect of sex on reperfusion therapy and early mortality after acute myocardial infarction.
Introduction
Despite major improvements in the treatment of acute myocardial infarction, the in-hospital mortality of women suffering from a myocardial infarction remains high, ranging from 9% [1 ' to 42%' 21 . This mortality is two to three times that observed in men. However, the real extent and causes of this increased mortality in women are still controversial. In particular, there is conflicting evidence as to whether female sex is, or is not, an independent risk factor for post-myocardial infarction mortality' 341 . One major limitation of previous studies concerns the selection of women for reperfusion therapy, as they have been excluded from most clinical trials in . Another important limitation is linked to the overall under-utilization of reperfusion interventions in women, compared to men, which may be due to 'illegitimate' treatment biases, or alternatively to differences between the eligibility of men and women for these procedures' 61 .
In an attempt to circumvent these limitations, the present report analyses the sex-specific in-hospital outcome of a cohort of 400 consecutive patients who were prospectively and systematically treated during acute myocardial infarction according to a maximal early reperfusion strategy, using direct angioplasty and intravenous thrombolysis with rescue angioplasty.
Methods
Four hundred consecutive patients with acute myocardial infarction (320 men and 80 women), who were admitted to hospital less that 6 h after symptom onset, Graph showing reperfusion strategy in men and women: most of the 400 patients underwent intravenous thrombolysis, except in cases of contraindication, diagnostic doubt or cardiogenic shock. In these cases, and for several patients admitted under 'ideal' conditions for direct angioplasty, emergency coronary angiography and direct angioplasty were performed. AMI = acute myocardial infarction; CI=contraindication; PTCA = percutaneous transluminal coronary angioplasty.
were treated according to the reperfusion strategy shown in Fig. 1 , and as described in a previous report' 71 , regardless of sex. Patients with contraindications to thrombolysis, an uncertain diagnosis or cardiogenic shock, and several patients admitted under 'ideal' conditions, underwent emergency coronary angiography, and if the infarct-related artery was occluded (grade 0 or 1 according to the Thrombolysis in Myocardial Infarction (TIMI) trial score), emergency direct angioplasty. Contraindications to thrombolytic therapy were defined as conditions associated with an increased bleeding risk (i.e. gastrointestinal bleeding, recent surgery, recent stroke, refractory high blood pressure, recent head trauma), and prolonged cardiopulmonary resuscitation (>15min). Age alone was never a contraindication to thrombolysis. Patients without cardiogenic shock or contraindications to thrombolysis received intravenous thrombolysis, using accepted protocols, and underwent 90-min emergency angiography to ascertain the patency of the infarct-related artery. If flow through the artery was TIMI grade 2 or 3, they were treated medically. If flow was TIMI 0 or 1, they underwent rescue angioplasty, provided that the operator considered the infarct-related artery suitable. Conventional medical therapy was prescribed for patients with poor physiological status (i.e. very elderly patients with severe co-morbidity and limited life expectancy or advanced mental deterioration) or contraindications to both thrombolysis and angioplasty, defined as impossibility of catheterization via the femoral approach due to proximal arterial obstruction of the lower limbs, patients with occlusion of a small infarct-related artery, and patients with angiographically-proven spontaneous reperfusion.
The diagnosis of acute myocardial infarction was based on conventional criteria: chest pain lasting more than 30 min and resistant to nitrates, with either typical electrocardiographic changes (ST-segment elevation >1 mV in two contiguous standard leads or >2mV in two contiguous chest leads) or giant T waves, and was always confirmed by high creatine kinase (>2 N). Angiographic patency was defined as a flow grade in the infarct-related vessel of >2 in the TIMI score. Multivessel disease was defined as the presence of >50% luminal diameter stenosis in at least two major epicardial arteries.
During the patients' hospital stay, they were given at least 250 mg aspirin daily, and intravenous heparin until predischarge angiography. All patients undergoing emergency angioplasty received 15 000IU heparin at the beginning of the procedure. All patients received beta-blockers, unless contraindicated. Before discharge, patients underwent a repeat coronary angiogram. Elective coronary bypass surgery was performed when severe triple-vessel disease or left main artery disease was present.
Statistical analysis
Statistical analysis was performed in three steps. The first step was bivariate analysis using the chi-square and Student's t-tests to compare the results for men and women, according to baseline clinical and angiographic characteristics, reperfusion therapy and immediate outcome. For the second step, the same tests were used to determine the prognostic factors relating to the inhospital mortality of this cohort. The third step was multivariate analysis using linear logistic regression. The variables used at this stage were those significantly linked to death in the bivariate analysis. Several models were compared by repeated maximum likelihood ratio tests, in order to determine the best model. Addition of the variable 'sex' to the best model was tested, to verify the absence or presence of improvement in the predictive power of the model. The goodness of fit of the final model was also assessed by the Hosmer-Lemeshow method 18 ': in this method, the samples are ranked according to their calculated risk, divided into 10 classes of equal size, and the distributions of the observed and expected numbers of deaths are then compared by the chi-square test.
Results

Population characteristics and outcome
Baseline clinical characteristics (Table 1) The study population comprised 320 men and 80 women admitted to our institution between June 1988 and Eur Heart J. Vol. 18. October 1997 174 (560) 137 (440) 160 ( January 1994. Several clinical characteristics differed in the men and women: women were older than the men (66-8 vs 57-2 years, / > =0001), more of them had systemic hypertension (50 vs 33%, / > <0-02), fewer were cigarette smokers (30 vs 79%, Z'<00001) and more had contraindications to thrombolysis (42-5 vs 28-5%, />=0-02). The causes of these contraindications were similar in the men and women: gastrointestinal bleeding and recent surgery accounted for approximately half of the exclusions in both gender groups; other causes were less frequent. Despite a trend towards a higher incidence of cardiogenic shock in the women than the men (8-7 vs 58%), the difference observed was not statistically significant (ns). A history of prior myocardial infarction was more frequent in the men than the women (12-8 vs 5%, P=005). There were no other significant differences between the major clinical characteristics considered for women and men.
A ngiographic characteristics Emergency coronary angiography was performed in 311/320 men (97-2%) and 74/80 women (92-5%) (ns). The severity of coronary artery disease, as well as the location and characteristics of the infarct-related artery, were exactly the same in the men and the women (Table 2) .
Reperfusion therapy (Table 3)
Intravenous thrombolysis was less frequently used in the women than the men (41-2 vs 58-1%, P=00l). There were no sex differences regarding the time from chest pain to treatment, success rate of thrombolysis, or use of rescue angioplasty after failed thrombolysis. Primary angioplasty was used in 34/80 women (42-5%) and 111/320 men (34-7%) (ns), with a similar period before treatment or success rate in both groups. Spontaneous reperfusion was angiographically documented in 6/80 women (7-5%) and 13/320 men (4%) (ns). Conventional medical treatment without reperfusion therapy was applied to 8-7% of the women and 3-2% of the men (F=003). Overall, reperfusion therapy was attempted in 73 women (91-3%) and 310 men (96-8%) during the acute phase (ns), and was angiographically-proven in 84% of the patients in both groups.
In-hospital outcome (Table 4)
Overall in-hospital mortality was markedly higher among the women than the men (18-7 vs 7-2%, ,P=0001). However, the higher mortality for the women was only observed in patients over 60 years old (Fig. 2) ; there were no deaths among women of 60 or less. The higher mortality observed in the older women was mainly due to the higher incidence of pump failure (11-3 vs 6-2%) and to fatal intracranial haemorrhage after thrombolytic therapy (91 vs 0-5%). Other causes such as ventricular rupture or arrhythmia were much less frequently involved. There were no major complications of primary angioplasty.
Prognostic factors Bivariate analysis
The results of bivariate analysis (Table 5) showed that the significant risk factors for mortality in the whole cohort of 400 patients were sex (/"=0-001), age (/ ) =0001), systemic hypertension (/ ) =002), cigarette smoking (/><0001), prior myocardial infarction (^=002), cardiogenic shock (/ > =0001), primary angioplasty (P<0001), and severe coronary disease (/ > =0001). These prognostic variables were those used in the multivariate analysis.
Multivariate analysis
Four prognostic models were compared: a logistic model, denoted M7, included the seven risk factors significantly related to mortality in bivariate analysis. Figure 2 Mortality rate according to age in men and women. This graph shows: (i) for each sex, the plots (x, y), where x is the age of the patient, and y equals 1 if the patient died after myocardial infarction, and y equals 0 if not. Male patients are plotted using small black circles and female patients using stars; (ii) for each sex, a smoothing spline of the curve y = f(x). This curve can be considered as a non-parametric estimation of the regression function of y (death) with respect to x (age). Since means are proportions when considering binary variables, the curves show the relationships between probability of death and age, without making any assumption about the shape of the relationship.
Primary angioplasty, although related to mortality, was not taken into account here because it was not considered as a baseline risk factor; a logistic model, denoted M7, so it can be compared to these models using likehood ratio tests; a model, denoted M0, with no risk factor. Comparison between M0 and M2 demonstrates that M2 is significantly better than M0. Table 6 summarizes the comparison between these models. The results show that M2 i.e. the 'age and shock' model, is significantly better than M0, and not significantly different from M3 and M7. This multivariate analysis provided two items of information: first, comparison of the different prognostic models with the random prediction showed that the best model was M2, which involved two variables, namely cardiogenic shock and age. Addition of the other five predictor variables affecting outcome in the bivariate analysis did not improve the goodness of fit of the 'age and shock' model; and second, addition of the variable 'sex' to this best model did not improve the goodness of fit of the model (/ > >0-5). Thus, female sex does not appear to be independently related to in-hospital outcome.
In addition to the repeated maximum likelihood ratio tests, the goodness of fit was confirmed using the Hosmer-Lemeshow method, i.e. the chi-square test with 8 degrees of freedom. The result was 2-73 (P>0-95).
Discussion
Sex differences in baseline characteristics
As observed in previous studies' 691 , our report shows that the coronary risk profiles are different for women and men: the women were older than men by an average of 10 years, and had a higher incidence of hypertension [101 , but were less likely to have a history of cigarette smoking 1 "" 131 or previous myocardial infarction
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. We found no sex-related differences in infarct location, rate of hypercholesterolaemia, or cardiogenic shock at admission. Unlike some authors'
1112I4~161 , but as reported by others' 13171 , we observed a similar prevalence of diabetes mellitus in both sexes. Although the rate of contraindications to thrombolysis upon admission was higher among women (42-5% vs 28-5, />=002), the most frequent motives for contraindications were similar in both groups, and were gastrointestinal bleeding and recent surgery. Despite these sex-related differences in baseline clinical features, emergency angiography did not show any differences between men and women either in the characteristics and location of the infarct-related artery, or in the severity of coronary artery disease. These results do not support those reported by Negus et al. li8 \ who found that young female survivors of a first infarction were more likely to have three vessel or left main coronary artery disease than males. However, their study was a retrospective assessment of a small series of selected young patients, which may have biased the conclusions. More recent data from the PAMI trial only showed a non-significant trend towards a lower incidence of multivessel disease in women than men' 14 '. Consequently, sex-related differences in the angiographic severity or extent of coronary artery disease, as evaluated by coronary angiography, apparently cannot account for differences in clinical outcome.
Sex-related differences in emergency reperfusion interventions and their immediate outcome
In a large number of studies, women were reported to be less likely than men to undergo intravenous thrombolysis, coronary angiography and invasive cardiac revascularization procedures in acute myocardial infarction 1619 23 \ Some of the authors concerned concluded that these differences in management during acute myocardial infarction persisted after adjustment for the most important clinical variables, such as age, diabetes mellitus and congestive heart failure' 2023 " 26 '. However, other authors argued that these differences disappeared after adjustment for confounding variables, and found no sex-related bias in treatment allocation [22>27>281 . These conflicting results are probably due in part to differences in patient selection and adjustment methods, and may also reflect a temporal trend in medical practices.
An important feature in the present study was that management strategies were similar in men and women with acute myocardial infarction: the triage scheme was the same for the whole cohort, regardless of sex, and aimed to achieve maximal early reperfusion rates. The rates of emergency angiography and of reperfusion interventions were in fact high (>90%) and similar in the men and women. Furthermore, it is important to note that successful reperfusion was angiographically documented in exactly 84% of the patients of each sex. The only difference in terms of patient management was a lower rate of thrombolysis in women than men (41 • 2% vs 58-1, / > =001). This was a direct consequence of the higher rate of contraindications to thrombolysis upon admission among the women, and should not be interpreted as a sex-related bias in treatment allocation. In patients ineligible for thrombolysis, primary angioplasty was always the treatment of choice, and conventional medical therapy was used as back-up for patients in whom any revascularization attempt was deemed unreasonable because of severe co-morbidity with limited life expectancy. The success rates of thrombolysis and of rescue angioplasty after failed thrombolysis, were similar in both groups, as was the use and success rate of primary angioplasty. Overall, the present results support the assumption that despite a higher incidence of contraindications to thrombolysis in women, tailored reperfusion therapy using intravenous thrombolysis, rescue and direct angioplasty can achieve equally early coronary patency rates in men and women during acute myocardial infarction. Thus, the higher in-hospital mortality among women noted in this study as well as in most previous reports cannot be solely explained by sex-related differences in the management of acute myocardial infarction.
Sex-related differences in in-hospital mortality
This study confirms that mortality in women suffering from an acute myocardial infarction is higher than in men. Despite the absence of difference in the severity of coronary artery disease, and despite a similar and high overall success rate of reperfusion interventions during the acute phase of myocardial infarction, the mortality in the female population was nearly three times that of the males (19% vs 7, />=0001). This higher mortality in women was observed in most previous studies 12   -11   '   13   -1517   -21   '   24   -29   -301 , but the exact role of sex in mortality remains controversial. One explanation for this controversy may be that adjustment for baseline characteristics such as age, which can be important confounding parameters, was not always performed. In all the reports published, women with acute myocardial infarction were on average older than men. However, conflicting results were found, even after adjustment for age and other important parameters. In the Multicenter Investigation of Infarct Size (MILIS), whose results were adjusted for age' 151 , in-hospital mortality was significantly higher in women than men (13 vs 7%), and the difference persisted after adjustment for baseline clinical characteristics other than age. Similarly, age-adjusted in-hospital mortality was significantly higher in women than men in the study by Greenland 24 -311 , a worse prognosis was reported for women but the difference compared to men disappeared after adjustment for age and comorbidity. The latter results suggest that the higher in-hospital mortality in women is due to differences in risk factors for subsequent mortality, particularly age, and that sex should not be considered an independent risk factor for mortality after myocardial infarction. In itself, the coexistence of such contradictory results supports the hypothesis that sex is not a clinically significant prognostic factor after acute myocardial infarction.
Our results are consistent with the latter assumption. Age and the presence of cardiogenic shock during the acute phase of myocardial infarction were the strongest predictors of in-hospital mortality in the present cohort. Furthermore, there was zero mortality among women of 60 or less vs 1-3% in men (ns). The aggressive patency-oriented approach used in the present cohort may have contributed to the excellent outcome in younger women. The excess mortality observed in women occurred in patients above 60, with parallel and sharp increases in mortality rates for both men and women with advancing age. Most cardiogenic shocks and severe co-morbid illnesses with contraindications to thrombolysis were encountered in elderly patients, and particularly in elderly women, which may in part explain the high mortality rate of older women, despite active attempts at reperfusion. This strongly suggests that age is the chief determinant of postmyocardial infarction mortality.
Study limitations
This was a single-centre cohort, and although the patients were consecutive, there may have been a recruitment bias. The number of patients studied, especially women, was relatively small; this number was too small to definitely exclude sex as an independent risk factor for mortality, and a larger series might have revealed other independent correlates of outcome, possibly related to sex. However, their relevance is likely to be of minor clinical importance.
Conclusion
The results of the present study suggest that, despite a lower rate of eligibility for intravenous thrombolysis, women should have the same access as men to invasive diagnostic and therapeutic procedures during acute myocardial infarction, with the same reperfusion rate. However, despite the absence of major sex-related differences in patient management and angiographic characteristics, in-hospital mortality remains significantly higher in women than in men. Nevertheless, female sex per se does not appear to be an independent predictor of early outcome. In this study, the best predictive model of in-hospital outcome combined the variables age and cardiogenic shock. Taking into account the absence of a significant difference between men and women in the incidence of cardiogenic shock, the higher mortality in women than men appears mainly related to their older age at the onset of acute myocardial infarction.
